CRSP insider buying
Every open-market purchase of CRISPR Therapeutics AG (CRSP) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$49.70K
Insiders buying (12m)1
Purchases on record1
Last purchase filedJan 27, 2026
In the last 12 months, 1 insider of CRISPR Therapeutics AG bought $49.70K of CRSP stock on the open market in 1 reported purchase. The most recent was filed on Jan 27, 2026: Patel Naimish (Chief Medical Officer) bought 1,508 shares at $32.96, worth $49.70K.
Get the next CRSP insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll CRSP insider purchases
| Filed | Insider | Value | Shares | Price | Stake | Trade | |
|---|---|---|---|---|---|---|---|
| Jan 27 | Patel NaimishChief Medical Officer | $49.70K | 1,508 | $32.96 | new | Apr 3 | SEC |